Home »
1994 Issues »
59 FR (05/27/1994) » X94-10527. Discovery Experimental and and Development, Inc.; Deprenyl Gelatin Capsules and Liquid (Deprenyl Citrate); Proposal to Refuse to Approve a New Drug Application; Opportunity for a Hearing
X94-10527. Discovery Experimental and and Development, Inc.; Deprenyl Gelatin Capsules and Liquid (Deprenyl Citrate); Proposal to Refuse to Approve a New Drug Application; Opportunity for a Hearing
[Federal Register Volume 59, Number 102 (Friday, May 27, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: X94-10527]
[[Page Unknown]]
[Federal Register: May 27, 1994]
VOL. 59, NO. 102
Friday, May 27, 1994
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 94N-0171]
Discovery Experimental and and Development, Inc.; Deprenyl
Gelatin Capsules and Liquid (Deprenyl Citrate); Proposal to Refuse to
Approve a New Drug Application; Opportunity for a Hearing
Correction
In notice document 94-12196 beginning on page 26239 in the issue of
Thursday, May 19, 1994, make the following correction:
On page 26239, in the second column, under DATES, in the second
line, ``June 30, 1994'' should read ``June 20, 1994''.
BILLING CODE 1505-01-D
Document Information
- Published:
- 05/27/1994
- Department:
- Food and Drug Administration
- Entry Type:
- Uncategorized Document
- Document Number:
- X94-10527
- Pages:
- 0-0 (1 pages)
- Docket Numbers:
- Federal Register: May 27, 1994, Docket No. 94N-0171